(Q24241665)

5

object named as

Constant Paul van Schayck

0 references

author name string

Ayalu A Reda

1

0 references

Janneke Kaper

2

0 references

Hurmuz Fikretler

3

0 references

Johan L Severens

Cochrane Database of Systematic Reviews

4

0 references

publication date

15 April 2009

0 references

published in

0 references

cites work

Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

A randomized controlled trial of financial incentives for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

The use and impact of incentives in population-based smoking cessation programs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

Patients at-risk for cost-related medication nonadherence: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

Measures of abstinence in clinical trials: issues and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

Economics of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

Cost-effective primary care-based strategies to improve smoking cessation: more value for money

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Psychological intervention and antidepressant treatment in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Healthcare financing systems for increasing the use of tobacco dependence treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Smoking cessation in a blue-collar population: results from an evidence-based pilot program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Economic Evaluations of Smoking Interventions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Counseling youth in tobacco-use prevention: determinants of clinician compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Neurobiology of nicotine addiction: implications for smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Update on pharmacologic options for smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Pharmacological approaches to smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

The impact of financial incentives and a patient registry on preventive care quality: increasing provider adherence to evidence-based smoking cessation practice guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Physician smoking-cessation actions: are they dependent on insurance coverage or on patients?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Biochemical verification of tobacco use and cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Pilot study of enhanced tobacco-cessation services coverage for low-income smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Managing smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Discrete choice experiment of smoking cessation behaviour in Japan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Smoking cessation guidelines for health professionals: an update. Health Education Authority

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Does insurance coverage for drug therapy affect smoking cessation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

An adolescent tobacco-use prevention trial in orthodontic offices

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021

The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004305.PUB3

7 January 2021